+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hydrochlorothiazide"

From
Bisoprolol Market Report 2025 - Product Thumbnail Image

Bisoprolol Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Lisinopril Market Report 2025 - Product Thumbnail Image

Lisinopril Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Losartan Global Market Report 2025 - Product Thumbnail Image

Losartan Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Losartan - Global Strategic Business Report - Product Thumbnail Image

Losartan - Global Strategic Business Report

  • Report
  • August 2025
  • 384 Pages
  • Global
From
Telmisartan - Global Strategic Business Report - Product Thumbnail Image

Telmisartan - Global Strategic Business Report

  • Report
  • August 2025
  • 477 Pages
  • Global
From
Lisinopril - Global Strategic Business Report - Product Thumbnail Image

Lisinopril - Global Strategic Business Report

  • Report
  • August 2025
  • 476 Pages
  • Global
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Hydrochlorothiazide is a diuretic drug used to treat high blood pressure and other cardiovascular conditions. It works by increasing the amount of salt and water that the kidneys remove from the blood, which helps to lower blood pressure. It is also used to reduce the risk of stroke in people with high blood pressure and to reduce the risk of heart attack in people with coronary artery disease. Hydrochlorothiazide is often prescribed in combination with other drugs to treat high blood pressure. Hydrochlorothiazide is a widely used drug in the cardiovascular market, as it is effective in treating high blood pressure and other cardiovascular conditions. It is generally well tolerated and has few side effects. It is also relatively inexpensive, making it an attractive option for many patients. Some companies that produce hydrochlorothiazide include Pfizer, Merck, and Novartis. Show Less Read more